Company page
Molecular Partners Ag
Molecular Partners AG is a public company based in Switzerland, trading under the ticker MOLN. The company has a market capitalization of approximately CHF 156.5 million. Molecular Partners focuses on developing innovative therapies for various diseases, leveraging its proprietary DARPins technology platform.
- Ticker
- MOLN:SIX
- Asset type
- Stock
- Market cap
- $156.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- SIX
- Currency
- CHF